\-\ Texto\\:\\ \ \(0\)\
\-\ asmptomatic\\ patient\\ with\\ palpably\\ enlarged\\ uterus\\.\ \(0\)\
\-\ none\\.\ \(8\)\
\-\ a\\ lobular\\,\\ heterogeneous\\ bladder\\ mass\\ that\\ measures\ \(0\)\
\-\ 3\\.7\\ x\\ 3\\.0\\ x\\ 2\\.4\\ cm\\ is\\ seen\\ arising\\ from\\ the\\ posterior\\ bladder\\ wall\\ and\\ extending\\ in\\ a\\ frond\\-like\\ manner\\ intraluminally\\.\\ this\\ mass\\ demonstrates\\ arterial\\ vascular\\ flow\\ along\\ the\\ periphery\\.\\ there\\ are\\ internal\\ areas\\ of\\ hypoechogenicity\\ that\\ may\\ be\\ partially\\ cystic\\.\\ \\ while\\ separate\\ from\\ the\\ uterus\\ and\\ appearing\\ to\\ arise\\ from\\ the\\ bladder\\ wall\\,\\ this\\ area\\ is\\ immediately\\ anterior\\ to\\ the\\ region\\ of\\ known\\ prior\\ cesaren\\ section\\.\ \(0\)\
\-\ endometriosis\ \(26\)\
\-\ endometriosis\ \(26\)\
\-\ transitional\\ cell\\ carcinoma\ \(13\)\
\-\ cystitis\ \(180\)\
\-\ post\\ radiation\\ change\ \(0\)\
\-\ postoperative\\ change\ \(4\)\
\-\ adherent\\ blood\\ clot\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ metastases\ \(207\)\
\-\ neurofibromatosis\ \(24\)\
\-\ patient\\ has\\ enlarged\\ uterus\\,\\ rule\\ out\\ fibroid\\.\ \(0\)\
\-\ asymptomatic\\ endometriosis\\ incidentally\\ discovered\\.\\ \\ having\\ come\\ across\\ several\\ of\\ these\\ cases\\ where\\ there\\ is\\ a\\ mass\\ in\\ the\\ bladder\\ that\\ extends\\ intraluminally\\ and\\ appears\\ mucosal\\,\\ i\\ have\\ learned\\ to\\ list\\ endometriosis\\ as\\ the\\ top\\ of\\ the\\ differential\\ when\\ it\\ is\\ in\\ young\\ women\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endometriosis\\:\\ 0\\.4261312601475169\ \(0\)\
\-\ bladder\\:\\ 0\\.2785807594961241\ \(0\)\
\-\ intraluminally\\:\\ 0\\.2582230172307737\ \(0\)\
\-\ uterus\\:\\ 0\\.23616469033382964\ \(0\)\
\-\ palpably\\:\\ 0\\.14352783552800685\ \(0\)\
\-\ cesaren\\:\\ 0\\.14352783552800685\ \(0\)\
\-\ learned\\:\\ 0\\.14352783552800685\ \(0\)\
\-\ the\\:\\ 0\\.1432650669643844\ \(0\)\
\-\ asmptomatic\\:\\ 0\\.13714850924344182\ \(0\)\
\-\ change\\:\\ 0\\.13601816569293118\ \(0\)\
\-\ hypoechogenicity\\:\\ 0\\.12911150861538684\ \(0\)\
\-\ enlarged\\:\\ 0\\.12236587512308925\ \(0\)\
\-\ that\\:\\ 0\\.11684281272747989\ \(0\)\
\-\ come\\:\\ 0\\.11533744861408377\ \(0\)\
\-\ wall\\:\\ 0\\.10919043885809114\ \(0\)\
\-\ from\\:\\ 0\\.1069332298553572\ \(0\)\
\-\ manner\\:\\ 0\\.10653281503687922\ \(0\)\
\-\ mass\\:\\ 0\\.10284491281283242\ \(0\)\
\-\ list\\:\\ 0\\.09942157285483362\ \(0\)\
\-\ fibroid\\:\\ 0\\.09849581440882423\ \(0\)\
\-\ is\\:\\ 0\\.09831325121750338\ \(0\)\
\-\ clot\\:\\ 0\\.09352638798472569\ \(0\)\
\-\ lobular\\:\\ 0\\.09110108069208618\ \(0\)\
\-\ periphery\\:\\ 0\\.09054897651750848\ \(0\)\
\-\ separate\\:\\ 0\\.0900155913867847\ \(0\)\
\-\ top\\:\\ 0\\.08759028409414518\ \(0\)\
\-\ across\\:\\ 0\\.08736711220331751\ \(0\)\
\-\ mucosal\\:\\ 0\\.08453555869000715\ \(0\)\
\-\ arise\\:\\ 0\\.08213671625558956\ \(0\)\
\-\ immediately\\:\\ 0\\.08213671625558956\ \(0\)\
\-\ section\\:\\ 0\\.08182203867599215\ \(0\)\
\-\ discovered\\:\\ 0\\.08182203867599215\ \(0\)\
\-\ women\\:\\ 0\\.08076773541559563\ \(0\)\
\-\ having\\:\\ 0\\.07737391596992282\ \(0\)\
\-\ partially\\:\\ 0\\.07702556178739549\ \(0\)\
\-\ incidentally\\:\\ 0\\.07646158188863847\ \(0\)\
\-\ young\\:\\ 0\\.07400464975217877\ \(0\)\
\-\ arterial\\:\\ 0\\.0739101548464844\ \(0\)\
\-\ extends\\:\\ 0\\.0739101548464844\ \(0\)\
\-\ measures\\:\\ 0\\.07317395718152515\ \(0\)\
\-\ appearing\\:\\ 0\\.0717153273553676\ \(0\)\
\-\ there\\:\\ 0\\.07142152103437588\ \(0\)\
\-\ arising\\:\\ 0\\.07131084866554989\ \(0\)\
\-\ rule\\:\\ 0\\.07123118594091053\ \(0\)\
\-\ where\\:\\ 0\\.07053181060208923\ \(0\)\
\-\ of\\:\\ 0\\.07025375498848846\ \(0\)\
\-\ to\\:\\ 0\\.06731105515395412\ \(0\)\
\-\ in\\:\\ 0\\.06697975027989235\ \(0\)\
\-\ appears\\:\\ 0\\.06572313301499355\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.06495816651013533\ \(0\)\
\-\ this\\:\\ 0\\.06167859321781312\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.06109924930835751\ \(0\)\
\-\ areas\\:\\ 0\\.06093319653211482\ \(0\)\
\-\ extending\\:\\ 0\\.0608508227601619\ \(0\)\
\-\ internal\\:\\ 0\\.060485386485523575\ \(0\)\
\-\ cases\\:\\ 0\\.06036543656905134\ \(0\)\
\-\ along\\:\\ 0\\.060128245828055094\ \(0\)\
\-\ flow\\:\\ 0\\.05977903250187584\ \(0\)\
\-\ radiation\\:\\ 0\\.05947499686698049\ \(0\)\
\-\ vascular\\:\\ 0\\.059250764741339695\ \(0\)\
\-\ out\\:\\ 0\\.058993136806040514\ \(0\)\
\-\ several\\:\\ 0\\.05888400327364916\ \(0\)\
\-\ patient\\:\\ 0\\.058381544449352125\ \(0\)\
\-\ differential\\:\\ 0\\.05831440787492059\ \(0\)\
\-\ area\\:\\ 0\\.05814055688499419\ \(0\)\
\-\ known\\:\\ 0\\.05810601602698657\ \(0\)\
\-\ while\\:\\ 0\\.058002846119574035\ \(0\)\
\-\ and\\:\\ 0\\.05563645899228005\ \(0\)\
\-\ when\\:\\ 0\\.054213455529237974\ \(0\)\
\-\ cystic\\:\\ 0\\.054052636195456305\ \(0\)\
\-\ region\\:\\ 0\\.05368366289870177\ \(0\)\
\-\ carcinoma\\:\\ 0\\.05368366289870177\ \(0\)\
\-\ blood\\:\\ 0\\.05212266479007898\ \(0\)\
\-\ cm\\:\\ 0\\.05154374169846705\ \(0\)\
\-\ cell\\:\\ 0\\.051340436370617935\ \(0\)\
\-\ these\\:\\ 0\\.05068112113942808\ \(0\)\
\-\ prior\\:\\ 0\\.050214599361047434\ \(0\)\
\-\ anterior\\:\\ 0\\.05011047353755325\ \(0\)\
\-\ none\\:\\ 0\\.04904713998948215\ \(0\)\
\-\ posterior\\:\\ 0\\.04640986758083289\ \(0\)\
\-\ it\\:\\ 0\\.04594114541707964\ \(0\)\
\-\ may\\:\\ 0\\.04516441541390202\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04508881048944659\ \(0\)\
\-\ have\\:\\ 0\\.04483443782871966\ \(0\)\
\-\ seen\\:\\ 0\\.04225299833977339\ \(0\)\
\-\ has\\:\\ 0\\.04099462705600167\ \(0\)\
\-\ be\\:\\ 0\\.03640749156299775\ \(0\)\
\-\ as\\:\\ 0\\.03605526962719038\ \(0\)\
\-\ are\\:\\ 0\\.03405557977137388\ \(0\)\
\-\ with\\:\\ 0\\.017573932897588383\ \(0\)\
